The prostate is a male gland, located underneath the bladder and wrapped around the water conduit in the penis (urethra). The important function of this gland is to produce semen, which is then stored in a smaller gland, referred to as the seminal vesicle, before being released through ejaculation. If the prostate becomes enlarged, it could place pressure on the bladder and urethra, the tube through which urine travels. This can cause a problem when passing urine, as it may also cause:
€ Sudden and frequent urges to urinate.
€ Problems with emptying the bladder completely.
€ Difficulty starting urination.
Numerous men worry an enlarged prostate means they have an increased risk of developing prostate cancer. However, this is not the case. Men who suffer from prostate enlargement, a common condition connected with aging, do not have a larger risk of prostate cancer when compared to men without an enlarged prostate. This problem is termed as Benign Prostatic Hyperplasia, or BPH. Around 60% of men with BPH, aged 60 or higher, have experienced prostate enlargement. The cause of prostate enlargement is unknown, but many experts agree it is linked to changes in hormone levels inside a man's body, a common result of aging.
When it comes to Benign Prostatic Hyperplasia treatment, there are many options. Medication for this condition consists of alpha-blockers, such as terazosin and doxazosin, as well as tamsulosin, which relax the prostate, along with 5-alphareductase inhibitors. Medications such as finasteride and dutasteride will shrink the prostate. Occasionally, the urgency to urinate is treated with anti-cholinergics, such as oxybutynin and tolteridine, which react directly with the bladder. These drugs can be utilized alone, or even in a blend with other medication. Potential side effects and drug interactions should be discussed with an urologist prior to use.
Additionally, there are more recently developed, minimally widespread treatments now available. These treatments are often performed by a clinic, including microwave treatments (TUMT trans-urethral microwave therapy), and treatments done under an anesthetic, such as TUNA (trans-urethral needle ablation). Both treatments heat the prostate and can relieve symptoms without the need for drugs.
Other new treatments include laser treatment with Holmium, Neodynium (YAG), and KTP (Green) lasers. These laser treatments remove obstructive tissue through a variety of methods: chopping it away (Holmium), killing/denaturing it (Neodynium), or superheating/vaporizing it (KTP, as well as Holmium). Much of this groundbreaking research with lasers for the treatment of BPH has been conducted in Australia and New Zealand. A major benefit of laser treatment options is the occurrence of less internal bleeding; bleeding difficulties seen associated with TURP is also usually lessened with the use of laser treatments. As a result, a medical center stay can be shorter, along with a quicker recovery period through this method.
€ Sudden and frequent urges to urinate.
€ Problems with emptying the bladder completely.
€ Difficulty starting urination.
Numerous men worry an enlarged prostate means they have an increased risk of developing prostate cancer. However, this is not the case. Men who suffer from prostate enlargement, a common condition connected with aging, do not have a larger risk of prostate cancer when compared to men without an enlarged prostate. This problem is termed as Benign Prostatic Hyperplasia, or BPH. Around 60% of men with BPH, aged 60 or higher, have experienced prostate enlargement. The cause of prostate enlargement is unknown, but many experts agree it is linked to changes in hormone levels inside a man's body, a common result of aging.
When it comes to Benign Prostatic Hyperplasia treatment, there are many options. Medication for this condition consists of alpha-blockers, such as terazosin and doxazosin, as well as tamsulosin, which relax the prostate, along with 5-alphareductase inhibitors. Medications such as finasteride and dutasteride will shrink the prostate. Occasionally, the urgency to urinate is treated with anti-cholinergics, such as oxybutynin and tolteridine, which react directly with the bladder. These drugs can be utilized alone, or even in a blend with other medication. Potential side effects and drug interactions should be discussed with an urologist prior to use.
Additionally, there are more recently developed, minimally widespread treatments now available. These treatments are often performed by a clinic, including microwave treatments (TUMT trans-urethral microwave therapy), and treatments done under an anesthetic, such as TUNA (trans-urethral needle ablation). Both treatments heat the prostate and can relieve symptoms without the need for drugs.
Other new treatments include laser treatment with Holmium, Neodynium (YAG), and KTP (Green) lasers. These laser treatments remove obstructive tissue through a variety of methods: chopping it away (Holmium), killing/denaturing it (Neodynium), or superheating/vaporizing it (KTP, as well as Holmium). Much of this groundbreaking research with lasers for the treatment of BPH has been conducted in Australia and New Zealand. A major benefit of laser treatment options is the occurrence of less internal bleeding; bleeding difficulties seen associated with TURP is also usually lessened with the use of laser treatments. As a result, a medical center stay can be shorter, along with a quicker recovery period through this method.
SHARE
